In summary, in a man with metastatic BCC, aberration of the PTCH1 gene was observed during the genomic evaluation of his liver metastasis and cutaneous BCC in situ that developed while he was being treated with nivolumab. This evidence concerns the gene PTCH1 and skin basal cell carcinoma.